Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2014 08:38 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation

NORTHVALE, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the continued expansion of Elite's intellectual property...
June 30, 2014 14:05 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014

Revenues Increase by 35%, Product Development Accelerating Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT NORTHVALE, N.J., June 30, 2014 (GLOBE NEWSWIRE) -- Elite...
April 14, 2014 07:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC

NORTHVALE, N.J., April 14, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a common stock purchase agreement with...
December 05, 2013 12:49 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201

NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in...
September 18, 2013 07:51 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride

NORTHVALE, N.J., Sept. 18, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the initial shipment of naltrexone hydrochloride 50 mg tablets...
April 23, 2013 08:23 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation

NORTHVALE, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the issuance of U.S. Patent No. 8,425,933 entitled...
April 22, 2013 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC

NORTHVALE, N.J., April 22, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a $10 million common stock purchase...